The end of the line? A case of drug resistance to third-line antiretroviral therapy
HIV drug resistance has been described in all antiretroviral drug classes and threatens the long-term success of HIV treatment. Here, we describe the first reported case of acquired resistance to the integrase strand transfer inhibitors in South Africa. This case illustrates the dilemma of treatment...
Main Authors: | Theresa M. Rossouw, Sonia Hitchcock, Mariëtte Botes |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2016-05-01
|
Series: | Southern African Journal of HIV Medicine |
Subjects: | |
Online Access: | https://sajhivmed.org.za/index.php/hivmed/article/view/454 |
Similar Items
-
Estimating qualification and factors associated with third line ART referral in the Western Cape
by: Sadiyya Sheik, et al.
Published: (2021-01-01) -
Antiretroviral drug resistance mutations among patients failing first-line treatment in Hanoi, Vietnam
by: Tien TV, et al.
Published: (2019-05-01) -
Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa
by: Denise Evans, et al.
Published: (2018-04-01) -
Treatment outcomes of first-line antiretroviral therapy in HIV-1-positive patients in Serbia
by: Jovana Kušić, et al.
Published: (2016-01-01) -
Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique
by: Andrea De Luca, et al.
Published: (2017-09-01)